• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

我们如何在脓毒症期间管理止血。

How we manage haemostasis during sepsis.

机构信息

Department of Haematology, University College London Hospital, London, UK.

Cardiometabolic Programme-NIHR UCLH/UCL BRC, London, UK.

出版信息

Br J Haematol. 2019 Apr;185(2):209-218. doi: 10.1111/bjh.15821. Epub 2019 Mar 3.

DOI:10.1111/bjh.15821
PMID:30828800
Abstract

Sepsis may be associated with activation of the coagulation system and, in its most severe form, may result in disseminated intravascular coagulation (DIC). Initially, there is thrombosis primarily affecting small and medium sized vessels and contributing to organ dysfunction, but continued activation results in consumption of coagulation factors. This results in prolongation of global coagulation parameters. Often thrombocytopenia is the initial feature in sepsis, which may be followed by prolongation of global coagulation assays, and in severe cases, associated with hypofibrinogenaemia, with overactivation of the fibrinolytic path. The end result is a bleeding phenotype. Scoring systems can be used to help identify patients at risk of DIC and aid in confirming a diagnosis of DIC utilising routine laboratory parameters. Discussion includes medical and blood product support of haemostasis, from thrombotic to bleeding states, in relation to sepsis trigger.

摘要

败血症可能与凝血系统的激活有关,在其最严重的形式下,可能导致弥散性血管内凝血(DIC)。最初,主要影响中小血管的血栓形成会导致器官功能障碍,但持续的激活会导致凝血因子的消耗。这会导致整体凝血参数的延长。在败血症中,血小板减少通常是最初的特征,随后可能会出现整体凝血检测的延长,在严重的情况下,还会伴有纤维蛋白原减少症,并伴有纤维蛋白溶解途径的过度激活。最终结果是出血表型。评分系统可用于帮助识别有发生 DIC 风险的患者,并利用常规实验室参数辅助确诊 DIC。讨论包括与败血症诱因相关的从血栓形成到出血状态的止血的药物和血制品支持。

相似文献

1
How we manage haemostasis during sepsis.我们如何在脓毒症期间管理止血。
Br J Haematol. 2019 Apr;185(2):209-218. doi: 10.1111/bjh.15821. Epub 2019 Mar 3.
2
Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.弥散性血管内凝血诊断与管理指南。英国血液学标准委员会。
Br J Haematol. 2009 Apr;145(1):24-33. doi: 10.1111/j.1365-2141.2009.07600.x. Epub 2009 Feb 12.
3
The haematological manifestations of sepsis.
J Antimicrob Chemother. 1998 Jan;41 Suppl A:17-24. doi: 10.1093/jac/41.suppl_1.17.
4
Newly Proposed Sepsis-Induced Coagulopathy Precedes International Society on Thrombosis and Haemostasis Overt-Disseminated Intravascular Coagulation and Predicts High Mortality.新提出的脓毒症诱导性凝血病先于国际血栓与止血学会弥漫性血管内凝血,并预测高死亡率。
J Intensive Care Med. 2020 Jul;35(7):643-649. doi: 10.1177/0885066618773679. Epub 2018 May 2.
5
Clinical course and outcome of disseminated intravascular coagulation diagnosed by Japanese Association for Acute Medicine criteria. Comparison between sepsis and trauma.根据日本急性医学协会标准诊断的弥散性血管内凝血的临床病程及转归:脓毒症与创伤的比较
Thromb Haemost. 2008 Dec;100(6):1099-105.
6
Roles of Coagulation Abnormalities and Microthrombosis in Sepsis: Pathophysiology, Diagnosis, and Treatment.凝血异常和微血栓形成在脓毒症中的作用:病理生理学、诊断和治疗。
Arch Med Res. 2021 Nov;52(8):788-797. doi: 10.1016/j.arcmed.2021.07.003. Epub 2021 Jul 31.
7
Sepsis and thrombosis.脓毒症与血栓形成。
Semin Thromb Hemost. 2013 Jul;39(5):559-66. doi: 10.1055/s-0033-1343894. Epub 2013 Apr 27.
8
Treatment effects of drotrecogin alfa (activated) in patients with severe sepsis with or without overt disseminated intravascular coagulation.重组人活化蛋白C对伴或不伴明显弥散性血管内凝血的严重脓毒症患者的治疗效果
J Thromb Haemost. 2004 Nov;2(11):1924-33. doi: 10.1111/j.1538-7836.2004.00955.x.
9
Communication from the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis on sepsis-induced coagulopathy in the management of sepsis.国际血栓与止血学会科学与标准化委员会关于脓毒症管理中脓毒症诱导的凝血障碍的通讯。
J Thromb Haemost. 2023 Jan;21(1):145-153. doi: 10.1016/j.jtha.2022.10.022. Epub 2022 Dec 22.
10
Disseminated intravascular coagulation in paediatrics.小儿弥散性血管内凝血
Arch Dis Child. 2017 Feb;102(2):187-193. doi: 10.1136/archdischild-2016-311053. Epub 2016 Aug 18.

引用本文的文献

1
Proinflammatory and prothrombotic conditions in JAK2V617F-positive MPN: a case of Lemierre's syndrome in essential thrombocythemia.JAK2V617F 阳性骨髓增殖性肿瘤中的促炎和促血栓形成状态:原发性血小板增多症合并勒米尔综合征 1 例。
Ann Hematol. 2025 Apr;104(4):2563-2570. doi: 10.1007/s00277-025-06234-z. Epub 2025 Mar 20.
2
Developing A Model to Predict Major Bleeding Among Hospitalized Patients Undergoing Therapeutic Plasma Exchange.建立一个预测接受治疗性血浆置换的住院患者大出血的模型。
J Clin Apher. 2025 Apr;40(2):e70013. doi: 10.1002/jca.70013.
3
The diagnosis of DIC: a current overview.
弥散性血管内凝血的诊断:当前概述
Front Med (Lausanne). 2025 Jan 31;12:1502628. doi: 10.3389/fmed.2025.1502628. eCollection 2025.
4
Fibrinogen contribution to clot strength in patients with sepsis and hematologic malignancies and thrombocytopenia-a prospective, single-center, analytical, cross-sectional study.纤维蛋白原对脓毒症、血液系统恶性肿瘤及血小板减少症患者凝血强度的影响——一项前瞻性、单中心、分析性横断面研究。
Res Pract Thromb Haemost. 2024 Mar 1;8(2):102362. doi: 10.1016/j.rpth.2024.102362. eCollection 2024 Feb.
5
The pathophysiology, diagnosis, and management of sepsis-associated disseminated intravascular coagulation.脓毒症相关弥散性血管内凝血的病理生理学、诊断及管理
J Intensive Care. 2023 May 23;11(1):24. doi: 10.1186/s40560-023-00672-5.
6
Daily combined measurement of platelet count and presepsin concentration can predict in-hospital death of patients with severe coronavirus disease 2019 (COVID-19).血小板计数和降钙素原浓度的联合日测可预测重症 2019 冠状病毒病(COVID-19)患者的住院死亡。
Int J Hematol. 2023 Jun;117(6):845-855. doi: 10.1007/s12185-023-03555-5. Epub 2023 Mar 15.
7
Anticardiolipin Autoantibodies as Useful Biomarkers for the Prediction of Mortality in Septic Patients.抗心磷脂自身抗体作为预测脓毒症患者死亡率的有用生物标志物。
J Immunol Res. 2022 May 31;2022:9775111. doi: 10.1155/2022/9775111. eCollection 2022.
8
Oxygen therapy for sepsis and prevention of complications.脓毒症的氧疗及并发症预防
Acute Crit Care. 2022 May;37(2):137-150. doi: 10.4266/acc.2021.01200. Epub 2022 Mar 17.
9
MicroRNA-363-3p/sphingosine-1-phosphate receptor 1 axis inhibits sepsis-induced acute lung injury via the inactivation of nuclear factor kappa-B ligand signaling.微小 RNA-363-3p/鞘氨醇 1-磷酸受体 1 轴通过抑制核因子 κB 配体信号通路抑制脓毒症诱导的急性肺损伤。
Exp Anim. 2022 Aug 5;71(3):305-315. doi: 10.1538/expanim.21-0160. Epub 2022 Jul 23.
10
Clotting Dysfunction in Sepsis: A Role for ROS and Potential for Therapeutic Intervention.脓毒症中的凝血功能障碍:活性氧的作用及治疗干预潜力
Antioxidants (Basel). 2021 Dec 30;11(1):88. doi: 10.3390/antiox11010088.